Global cervical cancer market to grow up to $4.1 billion by 2016
Published on January 21, 2010 at 7:10 AM
Research and Markets (http://www.researchandmarkets.com/research/f1661b/cervical_cancer)
has announced the addition of GlobalData's new report "Cervical
Cancer - Pipeline Analysis and Market Forecasts to 2016" to their
Cancer - Pipeline Analysis and Market Forecasts to 2016”
Cancer - Pipeline Analysis and Market Forecasts to 2016 GlobalData,
the industry analysis specialist's new report, "Cervical
Cancer - Pipeline Analysis and Market Forecasts to 2016" is an
essential source of information and analysis on the global cervical
cancer market. The report identifies the key trends shaping and driving
the market, and provides insight on the prevalent competitive landscape
and the emerging players expected to bring a significant shift in the
market positioning of the existing market leaders. Most importantly, the
report provides valuable insight on the pipeline products within the
global cervical cancer sector.
The Cervical Cancer Market is Forecast to Show Significant Growth until
GlobalData has estimated the global cervical cancer market to be valued
at $1.8 billion in 2009. It is expected to grow to $4.1 billion by 2016,
at a Compound Annual Growth Rate (CAGR) of 11.9% between 2009 and 2016.
This growth is primarily attributed to increased competition among the
existing cervical cancer vaccines in the market. The vaccines will be
primarily responsible for the growth of the market with the predicted
increase in their uptake and sales. The success of these vaccines has
driven a lot of companies into research activity.
Competition in Cervical Cancer Market Becoming More Intense
GlobalData analyzed that the current competition in the cervical cancer
market is becoming more intense due to increased competition between two
cervical cancer vaccines. Both the vaccines, Gardasil and Cervarix, are
trying to overtake the market share of each other. Merck's Gardasil,
which has been in the market for a long time, is facing competition from
GSK's Cervarix which was approved in 2009 in the US. There is
competition between them to expand the label indications, to provide
broader coverage against the HPV strains, for inclusion in national
immunization schedules around the world. These two vaccines form the
major cervical cancer market activity and the drugs have a very limited
role in the activity of the current market. These vaccines will be
responsible for major future market growth also.
Strategic Competitor Assessment of the Vaccines in Cervical Cancer Market
Note: This figure doesnt include drugs, as there is only one FDA
approved drug for late stage cervical cancer and some common
chemotherapy agents that are used widely for most types of cancer
Annualized global cervical cancer market revenues data from 2000 to
2009, forecast forward for 7 years to 2016.
Geographic markets covered in this report include the US, the UK,
Italy, Spain, Germany, France, and Japan.
Pipeline analysis data providing a split across different phases,
mechanism of action being developed and emerging trends.
Analysis of the current and future market competition in the global
cervical cancer market. Key market players covered include Eli Lilly
and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., SRI
International, and GSK plc.
Insightful review of the key industry drivers, restraints and
challenges. Each trend is independently researched to provide
qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market
characterization, unmet needs and implications for future market
associated with cervical cancer.
Reasons to buy
Develop and design your in-licensing and out-licensing strategies
through review of pipeline products and technologies and by
identifying companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and
driving the global cervical cancer market.
Drive revenues by understanding key trends, innovative products and
technologies, market segments and companies likely to impact the
global cervical cancer market in future.
Formulate effective sales and marketing strategies by understanding
the competitive landscape and by analyzing the performance of various
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage.
Organize your sales and marketing efforts by identifying the market
categories and segments that present maximum opportunities for
consolidations, investments and strategic partnerships.
What's the next big thing in the global cervical cancer market
landscape? - Identify, understand and capitalize.